Edition:
United States

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

621.85INR
3:46am EDT
Change (% chg)

Rs1.15 (+0.19%)
Prev Close
Rs620.70
Open
Rs629.60
Day's High
Rs636.70
Day's Low
Rs600.00
Volume
2,359,749
Avg. Vol
1,097,733
52-wk High
Rs994.00
52-wk Low
Rs600.00

Latest Key Developments (Source: Significant Developments)

Glenmark Pharma gets ANDA approval for nebivolol tablets
Sunday, 28 May 2017 11:16pm EDT 

May 29 (Reuters) - Glenmark Pharmaceuticals Ltd :Says Glenmark Pharmaceuticals receives ANDA approval for nebivolol tablets, 2.5 mg, 5 mg, 10 mg and 20 mg.Co may be eligible for 180 days of generic drug exclusivity for nebivolol tablets, 2.5 mg, 5 mg, 10 mg, and 20 mg.  Full Article

Glenmark to initiate clinical study for GBR 1342
Monday, 15 May 2017 08:00am EDT 

May 15 (Reuters) - Glenmark Pharmaceuticals Ltd :Glenmark pharmaceuticals to initiate clinical study for gbr 1342, second investigational new drug from immuno-oncology portfolio.  Full Article

Glenmark Pharma gets ANDA approval for fenofibrate capsules
Sunday, 9 Apr 2017 11:18pm EDT 

Glenmark Pharmaceuticals Ltd :Receives ANDA approval for fenofibrate capsules.  Full Article

Glenmark Pharma gets tentative ANDA approval from USFDA for milnacipran hydrochloride tablets
Thursday, 30 Mar 2017 11:14pm EDT 

Glenmark Pharmaceuticals Ltd :Receives tentative ANDA approval for milnacipran hydrochloride tablets.  Full Article

Glenmark Pharmaceuticals reports positive results from phase 3 trial of gsp 301
Wednesday, 29 Mar 2017 10:28am EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals reports positive results from a Phase 3 trial of GSP 301, Mometasone/Olopatadine fixed-dose combination nasal spray, in seasonal allergic rhinitis . In trial treatment with GSP 301 demonstrated statistically significant and clinically meaningful improvement from baseline .All investigational treatments administered in trial were well-tolerated.  Full Article

Glenmark Pharma gets ANDA approval from USFDA for clobetasol propionate ointment
Monday, 20 Mar 2017 11:38pm EDT 

Glenmark Pharmaceuticals Ltd :Says receives ANDA approval for clobetasol propionate ointment USP, 0.05%.  Full Article

Glenmark Pharma gets tentative FDA nod for fingolimod capsules
Monday, 20 Mar 2017 12:54am EDT 

Glenmark Pharmaceuticals Ltd :Says Glenmark Pharmaceuticals receives tentative ANDA approval for Fingolimod capsules, 0.5 mg.  Full Article

Glenmark Pharma says Ankleshwar plant gets EIR issued by USFDA
Tuesday, 14 Mar 2017 11:36pm EDT 

Glenmark Pharmaceuticals Ltd :Says Ankleshwar plant has received the EIR (Establishment Inspection Report) issued by the FDA.  Full Article

Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304
Tuesday, 7 Mar 2017 10:49am EST 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals receives FDA clearance of IND for GSP 304 .Plans to initiate clinical development with a Phase 2 study of GSP 304 in subjects with mild to moderate COPD.  Full Article

Glenmark Pharmaceuticals and Evestra announce partnership agreement for generic NuvaRing
Wednesday, 1 Mar 2017 01:58pm EST 

Glenmark Pharmaceuticals Inc USA: Glenmark Pharmaceuticals And Evestra, Inc. announce partnership agreement for generic NuvaRing . Glenmark Pharmaceuticals USA and Evestra, expect to file an Abbreviated New Drug Application in fiscal 2019 . Evestra will develop this product exclusively for Glenmark for U.S. Market .Has secured exclusive marketing and distribution rights for product, for U.S. Market.  Full Article

More From Around the Web

BRIEF-Glenmark Pharma gets ANDA approval for nebivolol tablets

* Says Glenmark Pharmaceuticals receives ANDA approval for nebivolol tablets, 2.5 mg, 5 mg, 10 mg and 20 mg